This provider's $3.9M in total Medicare payments ranks in the 97th percentile of Medical Oncology providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 67% in 2015
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $496.25 | $130.35 | 3.81x | $365.90 | $298.0K | 5.6K | 1.7K |
| 2015 | $454.42 | $121.02 | 3.75x | $333.40 | $498.6K | 8.1K | 2.5K |
| 2016 | $474.05 | $124.26 | 3.81x | $349.79 | $499.5K | 8.3K | 2.6K |
| 2017 | $669.41 | $164.98 | 4.06x | $504.43 | $394.8K | 6.3K | 2.0K |
| 2018 | $598.07 | $134.36 | 4.45x | $463.71 | $490.6K | 8.2K | 2.8K |
| 2019 | $495.56 | $115.56 | 4.29x | $380.00 | $451.5K | 8.3K | 2.7K |
| 2020 | $493.14 | $91.24 | 5.40x | $401.90 | $404.3K | 8.5K | 3.2K |
| 2021 | $554.85 | $106.64 | 5.20x | $448.21 | $419.5K | 6.7K | 2.6K |
| 2022 | $222.68 | $42.26 | 5.27x | $180.42 | $212.8K | 5.2K | 2.0K |
| 2023 | $205.27 | $45.35 | 4.53x | $159.92 | $270.3K | 6.9K | 2.7K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J2505 | Injection, pegfilgrastim, 6 mg | 274 | $819.2K | $3.0K | 4.53x |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | 5.7K | $686.1K | $119.35 | 3.01x |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | 6.1K | $502.0K | $82.49 | 3.22x |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | 2.7K | $300.8K | $111.24 | 4.24x |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | 2.8K | $227.3K | $81.96 | 3.28x |
| J9310 | Injection, rituximab, 100 mg | 268 | $163.5K | $610.07 | 2.94x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 13.1K | $117.9K | $9.03 | 4.15x |
| 99219 | Hospital observation care typically 50 minutes | 1.1K | $117.2K | $105.71 | 2.80x |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | 1.8K | $100.8K | $56.87 | 3.11x |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | 1.3K | $77.5K | $60.54 | 3.46x |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | 451 | $72.6K | $160.88 | 3.19x |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | 439 | $68.3K | $155.55 | 3.27x |
| J3490 | Unclassified drugs | 373 | $66.5K | $178.22 | 1.49x |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 1.1K | $56.5K | $53.74 | 4.04x |
| 36415 | Insertion of needle into vein for collection of blood sample | 11.8K | $41.2K | $3.49 | 3.16x |
| 74177 | CT scan of abdomen and pelvis with contrast | 220 | $39.7K | $180.31 | 4.35x |
| 38222 | Bone marrow biopsy and aspiration | 534 | $33.3K | $62.27 | 6.65x |
| 96417 | Infusion of different chemotherapy drug or substance into a vein up to 1 hour | 557 | $29.9K | $53.74 | 4.32x |
| J9041 | Injection, bortezomib, 0.1 mg | 936 | $29.3K | $31.29 | 3.64x |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | 520 | $29.3K | $56.31 | 3.34x |
This provider submits charges 3.82 times higher than what Medicare actually pays.
A markup ratio of 3.82x means for every $100 Medicare pays, this provider initially charges $382. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data